Jack Lin

Company: Harpoon Therapeutics

Job title: Director of New Technologies

Seminars:

ProTriTAC: A New Protease-Activated T Cell Engager Platform to Target Broadly Expressed Tumor Antigens 11:00 am

ProTriTAC is a T cell engager prodrug with tumor-restricted activity for improved safety Half-life extension is coupled to functional masking for added protection Expansion of therapeutic index was demonstrated with rodent and non-human primate modelsRead more

day: Day Two